Search by Drug Name or NDC
NDC 00378-5057-77 Pitavastatin Calcium 4 mg/1 Details
Pitavastatin Calcium 4 mg/1
Pitavastatin Calcium is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is PITAVASTATIN CALCIUM.
MedlinePlus Drug Summary
Pitavastatin is used together with diet, weight-loss, and exercise to reduce the amount of fatty substances such as low-density lipoprotein (LDL) cholesterol ('bad cholesterol') in the blood and to increase the amount of high-density lipoprotein (HDL) cholesterol ('good cholesterol') in adults. Pitavastatin is also used together with diet to decrease the amount of cholesterol and other fatty substances in the blood in teenagers and children 8 years of age and older who have familial heterozygous hypercholesterolemia (an inherited condition in which cholesterol cannot be removed from the body normally). Pitavastatin is in a class of medications called HMG-CoA reductase inhibitors (statins). It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Accumulation of cholesterol and fats along the walls of your arteries (a process known as atherosclerosis) decreases blood flow and, therefore, the oxygen supply to your heart, brain, and other parts of your body. Lowering your blood level of cholesterol and fats with pitavastatin has been shown to prevent heart disease, angina (chest pain), strokes, and heart attacks.
Related Packages: 00378-5057-77Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Pitavastatin
Product Information
NDC | 00378-5057 |
---|---|
Product ID | 0378-5057_b3cd7a77-9856-4bfe-9807-ade14a3c15f4 |
Associated GPIs | |
GCN Sequence Number | 066351 |
GCN Sequence Number Description | pitavastatin calcium TABLET 4 MG ORAL |
HIC3 | M4D |
HIC3 Description | ANTIHYPERLIPIDEMIC-HMGCOA REDUCTASE INHIB(STATINS) |
GCN | 28595 |
HICL Sequence Number | 036983 |
HICL Sequence Number Description | PITAVASTATIN CALCIUM |
Brand/Generic | Generic |
Proprietary Name | Pitavastatin Calcium |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | pitavastatin |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET, FILM COATED |
Route | ORAL |
Active Ingredient Strength | 4 |
Active Ingredient Units | mg/1 |
Substance Name | PITAVASTATIN CALCIUM |
Labeler Name | Mylan Pharmaceuticals Inc. |
Pharmaceutical Class | HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA206070 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00378-5057-77 (00378505777)
NDC Package Code | 0378-5057-77 |
---|---|
Billing NDC | 00378505777 |
Package | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5057-77) |
Marketing Start Date | 2023-11-02 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 2.34515 |
Pricing Unit | EA |
Effective Date | 2024-02-21 |
NDC Description | PITAVASTATIN 4 MG TABLET |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |